Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Rotigotine ER by UCB for Frontotemporal Dementia (FTD): Likelihood of Approval
Rotigotine ER is under clinical development by UCB and currently in Phase II for Frontotemporal Dementia (FTD). According to GlobalData,...